Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/20/2012EP2465531A1 Apoptosis-inducing polypeptides
06/20/2012EP2465523A1 FVIII-derived peptides and their use in tolerising haemophiliacs
06/20/2012EP2465522A1 Chemerin-15h and its use for treatment of inflammation and endotoxic shock
06/20/2012EP2465521A1 Stimulator of genital, sexual and reproductive function
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2465519A1 Treatment of endothelial dysfunction in diabetic patients
06/20/2012EP2465511A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2465510A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2465508A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/20/2012EP2464664A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
06/20/2012EP2464663A2 Engineered proteins including mutant fibronectin domains
06/20/2012EP2464656A1 Novel peptide and use thereof
06/20/2012EP2464377A1 Use of il-15 to increase thymic output and to treat lymphopenia
06/20/2012EP2464376A1 Method for repairing neurodegeneration
06/20/2012EP2464375A2 Prg4 treatment for interstitial cystitis
06/20/2012EP2464374A1 Separation and/or purification of pneumocandin b0 from c0
06/20/2012EP2464373A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
06/20/2012EP2464372A2 Agent for stimulating mobilization of endothelial progenitor cells
06/20/2012EP2464371A1 Methods for preventing or treating metabolic syndrome
06/20/2012EP2464370A1 Modified vasoactive intestinal peptides
06/20/2012EP2464369A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
06/20/2012EP2464368A1 Cathepsin c inhibitors
06/20/2012EP2464367A2 Methods of treating cancer using neurotrophin retargeted endopeptidases
06/20/2012EP2464366A2 Methods of treating cancer using growth factor retargeted endopeptidases
06/20/2012EP2464365A2 Methods of treating cancer using tachykinin retargeted endopeptidases
06/20/2012EP2464364A2 Methods of treating cancer using galanin retargeted endpeptidases
06/20/2012EP2464330A1 Oral care compositions containing human recombinant interleukin-1
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2303268B1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use
06/20/2012EP2146735B1 Compositions comprising sparc polypeptides
06/20/2012EP2099815B1 Novel amides acting on the adenosine receptors
06/20/2012EP2073829B1 Stabilized therapeutic small helical antiviral peptides
06/20/2012EP2029740B1 Use of polysaccharides for promotion of enzymatic activity
06/20/2012EP1912996B1 Macrocyclic inhibitors of hepatitis c virus
06/20/2012EP1853296B1 Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events
06/20/2012EP1799711B1 Protracted exendin-4 compounds
06/20/2012EP1755582B1 Pharmaceutical compositions for the prevention and treatment of atherosclerosis
06/20/2012EP1734938B1 Insulin highly respirable microparticles
06/20/2012EP1699821B1 Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS
06/20/2012EP1641359B1 Compositions and food products from oat
06/20/2012EP1487479B1 Mutant glycoproteins
06/20/2012EP1452541B1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
06/20/2012EP1280557B1 Method for the preparation of polymeric micelle via phase separation of block copolymer
06/20/2012EP1252182B1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
06/20/2012EP1240315B1 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof
06/20/2012CN1942201B Methods of modulating cytokine activity, related reagents
06/20/2012CN1835766B Osteogenesis promoter
06/20/2012CN102510758A Lactase preparation
06/20/2012CN102510757A Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59
06/20/2012CN102510756A Oncofetal antigen/immature laminin receptor peptides for the sensitization of dendritic cells for cancer therapy
06/20/2012CN102510755A Bifunctional stapled polypeptides and uses thereof
06/20/2012CN102505034A Method for preparing active polypeptide from corn protein powder
06/20/2012CN102504021A FBXL15 protein as well as inhibitor of FBXL15 protein and applications of FBXL15 protein and inhibitor
06/20/2012CN102504018A Melittin pamoate capable of being continuously released and preparation agent thereof
06/20/2012CN102504017A Novel Enterococcus and Streptococcus strains and bacteriocins
06/20/2012CN102504016A Amyloid fibrillar oligomer conformational epitope polypeptide and application thereof
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102499981A Compositions and methods for topical application and transdermal delivery of botulinum toxins
06/20/2012CN102499980A Application of polypeptides to preparation of medicament for treating or preventing rheumatoid arthritis
06/20/2012CN102499379A Preparation technology for compound aquatic organism collagen peptide-calcium complex, technology for preparing calcium supplement from complex, and application of calcium supplement
06/20/2012CN102499179A Method for establishing rat model with IgAN (immunoglobulin A nephropathy) glomerulosclerosis
06/20/2012CN102499177A Application of IgAN glomerular sclerosis rat model
06/20/2012CN101870734B Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
06/20/2012CN101684151B Protein matter with coagulation activity
06/20/2012CN101643501B Novel antibiotic and nucleotide sequence, preparation method and application thereof
06/20/2012CN101612385B Application of rLZ-8 in treating thrombopenia and preparation thereof
06/20/2012CN101612384B Application of polypeptide small molecule MLIF in preparing medicine for preventing and treating myocardial ischemia
06/20/2012CN101594879B Enzyme composition and use thereof
06/20/2012CN101332292B Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
06/20/2012CN101297655B Compound formulation for killing bacillus spore
06/20/2012CN101098709B Use of a trpc channel for the treatment of a cardiovascular disease
06/20/2012CN101072793B Il-7 variants with reduced immunogenicity
06/19/2012US8202980 Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
06/19/2012US8202979 siNA molecule comprising a double-stranded structure that down-regulates expression of a target nucleic acid, wherein said siNA molecule does not require a 2'-hydroxyl group containing ribonucleotide; treating viral diseases such as SARS (severe acute respiratory syndrome virus), herpes, hepatitis, HIV
06/19/2012US8202973 Method for the production of vitamin K-dependent proteins
06/19/2012US8202969 Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)
06/19/2012US8202966 Human Dickkopf-related protein and nucleic acid molecules and uses therefor
06/19/2012US8202860 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
06/19/2012US8202849 Methods and compositions for the inhibition of Stat5 in prostate cancer cells
06/19/2012US8202847 Mutant human CD80 and compositions for and methods of making and using the same
06/19/2012US8202846 Methods and compositions for RNA interference
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012US8202840 Enhanced ocular neuroprotection and neurostimulation
06/19/2012US8202839 Pharmaceutical composition of nanoparticles
06/19/2012US8202838 Methods for treatment of headaches by administration of oxytocin
06/19/2012US8202837 Glucagon-Like Peptide 1agonist administered once daily; via an injection device; tube has a gauge of 28 or greater; minimize burdensome regimens and site injection pain; Type I diabetes, Type II diabetes, obesity and hyperglycemia
06/19/2012US8202836 Modified PYY (3-36) peptides and their effects on feeding behavior
06/19/2012US8202835 Disease treatment via antimicrobial peptides or their inhibitors
06/19/2012US8202833 Composition containing biocompatible polymerization accelerator and polymerizable material
06/19/2012US8202724 Methods of controlling proliferation and differentiation of stem and progenitor cells
06/19/2012US8202696 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac
06/19/2012US8202540 Method for controlled production of ultrafine microparticles and nanoparticles
06/19/2012US8202525 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
06/19/2012US8202522 Skin cosmesis treatment with clostridia neurotoxins
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012US8202516 Phage derived antimicrobial activities
06/19/2012US8202513 Aryl potassium channel blockers and uses thereof
06/19/2012US8202512 Metabolic uncoupling therapy
06/19/2012CA2599754C Use of interleukin 17e for the treatment of cancer
1 ... 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 ... 3163